Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Stroes

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Preventive Cardiology|May 16, 2018
Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practiceJosé Tuñón, Magnus Bäck, Lina Badimón, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
European Heart Journal|June 10, 2024
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacyDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Expert Review of Cardiovascular Therapy|September 11, 2024
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based reviewMick P L Renkens, Casper F Coerkamp, Lars S Witte, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
Journal of Clinical Lipidology|April 9, 2016
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiencyRute Rodrigues, Marta Artieda, Diego Tejedor, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Preventive Cardiology|May 16, 2018
Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practiceJosé Tuñón, Magnus Bäck, Lina Badimón, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
European Heart Journal|June 10, 2024
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacyDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Expert Review of Cardiovascular Therapy|September 11, 2024
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based reviewMick P L Renkens, Casper F Coerkamp, Lars S Witte, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
Journal of Clinical Lipidology|April 9, 2016
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiencyRute Rodrigues, Marta Artieda, Diego Tejedor, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Pageof 5